Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.
about
The innate immune system in demyelinating diseaseImaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple SclerosisNanotechnology in neurology: Genesis, current status, and future prospectsThe Non-Obese Diabetic Mouse Strain as a Model to Study CD8(+) T Cell Function in Relapsing and Progressive Multiple SclerosisPotential Suppressive Effects of Two C60 Fullerene Derivatives on Acquired ImmunityFullerene-biomolecule conjugates and their biomedicinal applications.Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain barrier disruption: implications for the pathogenesis of multiple sclerosisTranscriptional alteration of matrix-related gene expression in cultured human disc cells by nanoparticles of a bismethanophosphonate fullerene.Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice.A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis.CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis.Evaluation of the fullerene compound DF-1 as a radiation protector.In vivo evidence of glutamate toxicity in multiple sclerosis.Review: Mitochondria and disease progression in multiple sclerosisPathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis.Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.Application of fullerenes in nanomedicine: an update.Xanthine oxidase mediates axonal and myelin loss in a murine model of multiple sclerosisDeletion of mitochondrial anchoring protects dysmyelinating shiverer: implications for progressive MS.Blocking GluR2-GAPDH ameliorates experimental autoimmune encephalomyelitisAstrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase.Effect of intra-membrane C60 fullerenes on the modulus of elasticity and the mechanical resistance of gel and fluid lipid bilayers.Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis.Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development.The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis.Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitisNeuropathic pain in animal models of nervous system autoimmune diseases.Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammationModeling the heterogeneity of multiple sclerosis in animalsNanomedicine in cerebral palsy.Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies.Demyelinated axons and motor function are protected by genetic deletion of perforin in a mouse model of multiple sclerosis.Neuromuscular electrical stimulation and dietary interventions to reduce oxidative stress in a secondary progressive multiple sclerosis patient leads to marked gains in function: a case report.Neurodegenerative disorders and nanoformulated drug development.Absence of system xc- on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis.Multiple sclerosis: experimental models and reality.
P2860
Q24597958-D5AD7240-67D5-44F1-9389-64BD7239A4B0Q26744629-872D17D0-3BB6-4E03-BCAD-A79A86013184Q26771772-BEBA4DB2-09DC-4B70-967E-AB4F63246B49Q26777944-C154CC77-60E6-41D9-943A-AD490841D515Q28390965-719F11C4-316F-4079-986C-9E43675A4E03Q28393292-5AFB0C5F-AED7-45BC-9A33-484D637AE270Q28910423-0FB6175F-DFC3-44A7-BF89-BBCAC0F6A595Q30450761-E1DBB22A-A874-4A48-A491-7735013232EFQ30478676-D5470E86-1E3E-4F74-9CF7-B6452175BF82Q33367112-95871AD1-E94D-438E-AA8E-10AB01F7AF89Q33725044-DA6FD9CE-5022-4A82-98D6-5ECC9BA0BD61Q33881319-122E1E8A-CBB5-4466-8BAC-7E2A6AB3D356Q34081836-F11AB76F-EA77-4139-9D56-5966C86ECB4AQ34308687-1F5569F8-BC0D-4496-BE1E-8BC9A12099DFQ34491978-BE9D7FA9-0A6B-43E5-B05A-181FC31A102CQ34632490-E48043D3-19A3-422E-B020-7128D435F25BQ34803596-03A68C7F-1610-4B04-9115-CF24EF6B2D8AQ34949303-65D8D4D3-E584-4463-8E04-6807D348ACDCQ35236885-4C6C154A-76CE-488F-915B-1D997676FEE2Q35469598-118F19C0-62B3-479A-8256-77058313397AQ35540927-A0956181-E182-46DD-8312-20BEF746B5D3Q35670887-1C0DB872-865E-4092-859E-3F1B19C7192AQ35792888-3279E971-99EC-47D4-8EF0-7597CE233FC5Q35867011-3B20A6B1-E179-4785-9891-87DB70AD43CAQ36055389-9A3002AC-FAA7-448F-BA69-9F1416BEFB6FQ36112101-DBAC26C0-CDE9-4C95-B93B-26C72310F31CQ36371175-77470AAD-2686-46C0-9760-37993E84DFB9Q36610373-0E0F0328-286A-447E-9A55-C690EF10DCE3Q36869524-8C03B85C-CA02-4808-BD98-5F76724334F0Q36887316-988CEDE0-E326-4381-BC10-A7375EA8159CQ37081950-5D329F7C-0632-4A21-8B71-F4801AEF0167Q37119854-6C36D991-C14C-410A-AC55-A172EDAAFBF3Q37281194-4062576C-CE9A-49EA-85CC-A664D2A59BA8Q37352700-76AE5547-2619-4B48-B5C7-3564908E3909Q37397820-9AA50289-EC9F-41C8-BB8C-C132CB2E2434Q37399033-02715D58-8656-456E-AA1F-E086741E7F85Q37403476-005F571E-A8C5-487A-99F1-396C0249910AQ37538771-D4B2A4C7-B95A-4B81-B0EC-9AF6DA6B1B0BQ37586538-3C7CD842-B111-4353-A36F-4C01FC8B0EA4Q37596784-137D8969-EB55-4ECF-B0DF-B5A36055B933
P2860
Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Reversal of axonal loss and di ...... rogressive multiple sclerosis.
@ast
Reversal of axonal loss and di ...... rogressive multiple sclerosis.
@en
type
label
Reversal of axonal loss and di ...... rogressive multiple sclerosis.
@ast
Reversal of axonal loss and di ...... rogressive multiple sclerosis.
@en
prefLabel
Reversal of axonal loss and di ...... rogressive multiple sclerosis.
@ast
Reversal of axonal loss and di ...... rogressive multiple sclerosis.
@en
P2093
P2860
P50
P356
P1476
Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis
@en
P2093
Alexandre S Basso
Alon Monsonego
Amnon Bar-Shir
Dan Frenkel
Francisco J Quintana
Lindsay Puckett
Sanja Petrovic-Stojkovic
Yoni Engel
P2860
P304
P356
10.1172/JCI33464
P407
P577
2008-04-01T00:00:00Z